PseudoCell: Hard Negative Mining as Pseudo Labeling for Deep Learning-Based Centroblast Cell Detection
<italic>Background:</italic> Deep learning models for patch classification in whole-slide images (WSIs) have shown promise in assisting follicular lymphoma grading. However, these models often require pathologists to identify centroblasts and manually provide refined labels for model opt...
Saved in:
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
IEEE
2024-01-01
|
Series: | IEEE Open Journal of Engineering in Medicine and Biology |
Subjects: | |
Online Access: | https://ieeexplore.ieee.org/document/10542389/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | <italic>Background:</italic> Deep learning models for patch classification in whole-slide images (WSIs) have shown promise in assisting follicular lymphoma grading. However, these models often require pathologists to identify centroblasts and manually provide refined labels for model optimization. <italic>Objective:</italic> To address this limitation, we propose <italic>PseudoCell</italic>, an object detection framework for automated centroblast detection in WSI, eliminating the need for extensive pathologist's refined labels. <italic>Methods:</italic> <italic>PseudoCell</italic> leverages a combination of pathologist-provided centroblast labels and pseudo-negative labels generated from undersampled false-positive predictions based on cell morphology features. This approach reduces the reliance on time-consuming manual annotations. <italic>Results:</italic> Our framework significantly reduces the workload for pathologists by accurately identifying and narrowing down areas of interest containing centroblasts. Depending on the confidence threshold, <italic>PseudoCell</italic> can eliminate 58.18-99.35% of irrelevant tissue areas on WSI, streamlining the diagnostic process. <italic>Conclusion:</italic> This study presents <italic>PseudoCell</italic> as a practical and efficient prescreening method for centroblast detection, eliminating the need for refined labels from pathologists. The discussion section provides detailed guidance for implementing <italic>PseudoCell</italic> in clinical practice. |
---|---|
ISSN: | 2644-1276 |